Magnesium as Adjuvant for Sciatic Block
- Registration Number
- NCT02198547
- Lead Sponsor
- Campus Bio-Medico University
- Brief Summary
The aim of the study is to evaluate if Magnesium added to ropivacaine can reduce onset time and can enhance offset time.
- Detailed Description
Patients are randomly divided into two groups: group "M" (Ropivacaina 7,5 mg/ml with Mg 4 mg/Kg)and group"C" (without Mg).
Standard monitoring is applied to each patient in perioperative period. An indipendent observer collect data: time to perform block, sensitivity onset,motor onset, pain during surgery and complication.
In the post-operative period till 24 hours for each patient is evaluated off-set time, pain and analgesic consumption.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- given consent
- allux valgus correction surgery
- allergy to local anesthetic
- infection in the site of puncture
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ropivacaine Ropivacaine Patients undergoing allux valgus correction with locoregional anesthesia with ropivacaine 7,5 mg/ml, without MG Ropivacaine Magnesium sulfate Magnesium Sulfate Locoregional anesthesia for valgus allux correction with ropivacaine 7,5 mg/ml and Mg 4 mg/Kg. Sciatic block at popliteal level.
- Primary Outcome Measures
Name Time Method Evaluation of Mg as adjuvant to local anesthetic Till 24 hours We evaluate if Mg affects onset and offset time of ropivacaine 7,5 mg/ml in sciatic block at popliteal level
- Secondary Outcome Measures
Name Time Method Post-operative pain 24 hours Evaluation of pain with NRS scale
post-operative pain 12 hours Evaluation of pain with NRS scale
Post-operative analgesic consumption till 24 hours We evaluate consumption of opioid and non-opioid analgesic used in the post-operative period.
Trial Locations
- Locations (1)
Campus Bio-Medico
🇮🇹Rome, Italy